An official Canadian panel on Tuesday said people who received a first shot of AstraZeneca PLC's (AZN.L) COVID-19 vaccine can choose to receive a different shot for their second dose, dealing another potential blow to the pharmaceutical giant.
US News: NEW DELHI: The Covid-19 pandemic has killed at least 3,551,488 people worldwide since the virus first emerged in December 2019, according to an AFP co.
By Syndicated Content
Jun 1, 2021 | 10:59 AM
OTTAWA (Reuters) -An official Canadian panel on Tuesday said people who received a first shot of AstraZeneca PLC’s COVID-19 vaccine can choose to receive a different shot for their second dose, dealing another potential blow to the pharmaceutical giant.
The non-binding recommendation from the National Advisory Committee on Immunization (NACI) means Canadians can choose to get second doses from Moderna Inc or Pfizer Inc. This could hit demand for AstraZeneca’s vaccine, which has been linked to reports of blood clots that, while extremely rare, can be fatal.
NACI said Denmark, Finland, France, Germany, Norway, Spain and Sweden, citing the clots, had already been offering second doses from Moderna and Pfizer to people who had received their first shots from AstraZeneca.